Ranbaxy Continues Drag On Daiichi Sankyo Quarterly Reports
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories Ltd. remains an albatross around the neck of Daiichi Sankyo, which recorded a loss for the third quarter of its fiscal year, also lowering its profit outlook for the period.